Colin Hopper

Dr. Colin Hopper


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2000 in The Lancet Oncology
Verified
Journal Article
Closed access
CHColin Hopper
Colin Hopper

20 April 2010 in Head & Neck Oncology
Verified
Journal Article
Open access
PDF file
Waseem JerjesWaseem Jerjes
Waseem Jerjes
TUTahwinder Upile
Tahwinder Upile
APAviva Petrie
Aviva Petrie
ARAndrew Riskalla
Andrew Riskalla
ZHZaid Hamdoon
Zaid Hamdoon
CHColin Hopper
Colin Hopper
The incidence of oral squamous cell carcinoma remains high. Oral and oro-pharyngeal carcinomas are the sixth most common cancer in the world. Several clinicopathological parameters have been implicated in prognosis, recurrence and survival, following oral squamous cell carcinoma. In this retrospective analysis, clinicopathological parameters of 115 T1/T2 OSCC were studied and compared to recurrence and death from tumour-related causes.

12 April 2004 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
CHColin Hopper
Colin Hopper
AKAlexander Kübler
Alexander Kübler
HLHarry Lewis
Harry Lewis
ITI. Bing Tan
I. Bing Tan
GPGraham Putnam
Graham Putnam
TGthe Foscan 01 Study Group
the Foscan 01 Study Group
Surgery and radiotherapy are standard treatments for early oral squamous cell carcinoma, both resulting in good tumour control. However, neither of these modalities is without consequent functional or cosmetic impairment, and there are patients in whom both are contraindicated. Furthermore, there is a significant risk of metachronous tumours developing in the oral cavity, and salvage or retreatment with either surgery or radiotherapy poses difficulties. Photodynamic therapy (PDT) offers the potential for improved functional and cosmetic outcomes, while achieving comparable tumour control. We conducted an open‐label, multicentre study to assess the efficacy and safety of meta‐tetrahydroxyphenylchlorin (mTHPC) in patients with early oral cancer. One hundred twenty‐one patients received intravenously administered mTHPC, followed 96 hr later by illumination of the tumour surface with 652 nm laser light. Of these patients, 114 were protocol compliant. A complete tumour response was achieved in 85% of protocol‐compliant patients (97 of 114 patients). A complete response was maintained in 85% of responders at 1 year and in 77% at 2 years. One‐ and 2‐year actuarial survival rates were 89% and 75%, respectively. In the opinion of the investigators, tumour clearance was accompanied by excellent cosmetic and functional results, without impact on the patients' performance status. Mild‐to‐moderate pain at the treatment site, a recognised side effect of PDT in the oral cavity, was reported by 82% of patients but was manageable with appropriate analgesia. Mild‐to‐moderate skin photosensitivity reactions were reported for 13% of patients. mTHPC offers an effective alternative treatment for early oral squamous cell carcinoma. It is associated with excellent functional and cosmetic results and can be used in conjunction with other standard therapies.

14 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Waseem JerjesWaseem Jerjes
Waseem Jerjes
Theodossis A. TheodossiouTheodossis A. Theodossiou
Theodossis A. Theodossiou
HHHenry Hirschberg
Henry Hirschberg
AHAnders Høgset
Anders Høgset
Anette WeyergangAnette Weyergang
Anette Weyergang
Kristian BergKristian Berg
Kristian Berg
Photochemical internalisation (PCI) is a unique intervention which involves the release of endocytosed macromolecules into the cytoplasmic matrix. PCI is based on the use of photosensitizers placed in endocytic vesicles that, following light activation, lead to rupture of the endocytic vesicles and the release of the macromolecules into the cytoplasmic matrix. This technology has been shown to improve the biological activity of a number of macromolecules that do not readily penetrate the plasma membrane, including type I ribosome-inactivating proteins (RIPs), gene-encoding plasmids, adenovirus and oligonucleotides and certain chemotherapeutics, such as bleomycin. This new intervention has also been found appealing for intracellular delivery of drugs incorporated into nanocarriers and for cancer vaccination. PCI is currently being evaluated in clinical trials. Data from the first-in-human phase I clinical trial as well as an update on the development of the PCI technology towards clinical practice is presented here.

1 September 2016 in The Lancet Oncology
Verified
Journal Article
Closed access
ASAhmed A Sultan
Ahmed A Sultan
WJWaseem Jerjes
Waseem Jerjes
KBKristian Berg
Kristian Berg
AHAnders Høgset
Anders Høgset
CMCharles A Mosse
Charles A Mosse
CHColin Hopper
Colin Hopper

25 May 2006 in Head & Face Medicine
Verified
Journal Article
Open access
PDF file
Waseem JerjesWaseem Jerjes
Waseem Jerjes
MEMohammed El-Maaytah
Mohammed El-Maaytah
BSBrian Swinson
Brian Swinson
BBBilquis Banu
Bilquis Banu
TUTahwinder Upile
Tahwinder Upile
CHColin Hopper
Colin Hopper
The records of 1087 patients who underwent surgical removal of third molar teeth were prospectively examined to analyse the possible relationship between postoperative complications and the surgeon's experience parameter. Seven surgeons (three specialists in surgical dentistry [specialists SD] and four oral and maxillofacial Senior House Officers [OMFS residents]) carried out the surgical procedures. For each patient, several variables were recorded including age, gender, radiographic position of extracted teeth, treating surgeon, duration of surgery and postoperative complications. Analysis of the data revealed some differences in the incidence of complications produced by the specialists SD and OMFS residents. The main statistically relevant differences were increase the incidences of trismus, nerve paraesthesia, alveolar osteitis and infection in the resident-treated group, while the specialist-treated group showed higher rates of post-operative bleeding. The higher rate of postoperative complications in the resident-treated group suggests that at least some of the complications might be related to surgical experience. Further work needs to compare specialists of training programmes with different years of experience, using large cross – sectional studies.